Bicara Therapeutics (BCAX) Return On Equity

BCAX Annual ROE

34.94%
-3.36%-8.77%

01 December 2023

BCAX ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAX Quarterly ROE

-28.19%
-42.31%-299.65%

30 September 2024

BCAX Quarterly ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BCAX ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.8%-
3 y3 years-8.8%-
5 y5 years-8.8%-

BCAX ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-8.8%at low-283.5%at low
5 y5-year-8.8%at low-283.5%at low
alltimeall time-8.8%at low-283.5%at low

Bicara Therapeutics ROE History

DateAnnualQuarterly
Sept 2024
-
-28.19%(-299.6%)
June 2024
-
14.12%(-8.1%)
DateAnnualQuarterly
Dec 2023
34.94%(-8.8%)
15.36%
Dec 2022
38.30%
-

FAQ

  • What is Bicara Therapeutics annual return on equity?
  • What is the all time high annual ROE for Bicara Therapeutics?
  • What is Bicara Therapeutics annual ROE year-on-year change?
  • What is Bicara Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Bicara Therapeutics?

What is Bicara Therapeutics annual return on equity?

The current annual ROE of BCAX is 34.94%

What is the all time high annual ROE for Bicara Therapeutics?

Bicara Therapeutics all-time high annual return on equity is 38.30%

What is Bicara Therapeutics annual ROE year-on-year change?

Over the past year, BCAX annual return on equity has changed by -3.36% (-8.77%)

What is Bicara Therapeutics quarterly return on equity?

The current quarterly ROE of BCAX is -28.19%

What is the all time high quarterly ROE for Bicara Therapeutics?

Bicara Therapeutics all-time high quarterly return on equity is 15.36%